A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.
Manufactured by
GeneCker Co., Ltd.
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENETRON HEALTH (BEIJING) CO., LTD
China · 6 relevant products
Intelligenome
United States · 2 relevant products
Eone-Diagnomics Genome Center
South Korea · 2 relevant products
45 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 25 relevant matches
GENETRON HEALTH (BEIJING) CO., LTD · China
Comprehensive genomic sequencing platform for cancer diagnosis and characterization. Utilizes next-generation sequencing technology to identify genetic mutations and alterations in tumor samples. Supports treatment selection and clinical decision-making for oncology patients.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Eone-Diagnomics Genome Center · South Korea
Liquid biopsy diagnostic platform for comprehensive genomic analysis and disease screening. Enables detection of genetic markers and abnormalities through blood-based testing.
22 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products